Compositions – Cefpodoxime 200mg + Clavunate Acid 125mg
PR-POD CV 325 is a combination antibiotic formulation containing Cefpodoxime Proxetil and Potassium Clavulanate, designed to effectively treat a wide range of bacterial infections. This advanced combination offers enhanced antibacterial coverage by helping combat bacteria that may develop resistance to conventional antibiotics.
Cefpodoxime Proxetil works by inhibiting the formation of bacterial cell walls, which are essential for bacterial growth and survival. Potassium Clavulanate acts as a beta-lactamase inhibitor, helping protect Cefpodoxime from bacterial resistance mechanisms and enhancing its effectiveness against susceptible bacteria.
Respiratory Tract Infections
Urinary Tract Infections (UTIs)
Skin & Soft Tissue Infections
Ear Infections
Other Bacterial Infections
Cefpodoxime Proxetil
A third-generation cephalosporin antibiotic that kills bacteria by preventing the formation of their protective cell walls, leading to bacterial destruction.
Potassium Clavulanate
A beta-lactamase inhibitor that helps prevent bacterial resistance and enhances the antibacterial activity of Cefpodoxime against resistant bacterial strains.
PR-POD CV 325 is effective against bacterial infections only and is not effective against viral infections such as the common cold or flu.
PR-POD CV 325 Tablets provide broad-spectrum antibacterial protection, helping ensure effective infection management and supporting a faster return to health.
| Packing/ Type | 10×10 Alu/Alu |
|---|
AAYI LIFE CARE is committed to delivering high-quality pharmaceutical products with trusted manufacturing standards, ethical business practices, and customer-focused healthcare solutions. We provide PCD Pharma Franchise opportunities and Third-Party Manufacturing services across India with a strong focus on quality, affordability, and timely delivery.
© 2026 AAYI LIFE CARE. All rights reserved.